Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
33.30
-0.27 (-0.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Kymera Therapeutics Employees
Kymera Therapeutics had 188 employees as of December 31, 2024. The number of employees increased by 1 or 0.53% compared to the previous year.
Employees
188
Change (1Y)
1
Growth (1Y)
0.53%
Revenue / Employee
$250,383
Profits / Employee
-$1,190,734
Market Cap
2.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 188 | 1 | 0.53% |
| Dec 31, 2023 | 187 | 20 | 11.98% |
| Dec 31, 2022 | 167 | 26 | 18.44% |
| Dec 31, 2021 | 141 | 66 | 88.00% |
| Dec 31, 2020 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
KYMR News
- 4 days ago - Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader - GlobeNewsWire
- 17 days ago - Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer - GlobeNewsWire
- 2 months ago - Kymera Therapeutics, Inc. (KYMR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Kymera Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 3 months ago - Kymera Therapeutics to Participate in Upcoming February Investor Conferences - GlobeNewsWire
- 3 months ago - Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs - GlobeNewsWire
- 3 months ago - Kymera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14 - GlobeNewsWire
- 5 months ago - Kymera: Protein Degradation Could Drive Dupixent-Like Value - Seeking Alpha